Human Anti-CD47 Recombinant Antibody (TAB-303LC) (CAT#: TAB-303LC)
This product is a recombinant human antibody that recognizes CD47 (cluster of differentiation 47). The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.
Specific Inquiry
WB
Figure 1 Anti-Human CD47 Recombinant Antibody (TAB-303LC) in WB
Western blot analysis was performed with 0.1 µg (lane 1), 0.3 µg (lane 2) and 0.6 µg (lane 3) recombinant CD47 protein onto a 12% Tris-HCl polyacrylamide gel. Goat anti-Human IgG HRP secondary antibody at a dilution of 1:8,000 for one hour.
ELISA
Figure 2 Anti-Human CD47 Recombinant Antibody (TAB-303LC) in ELISA
ELISA analysis of TAB-303LC was performed by coating with CD47 antigen. Then blocked with BSA, and incubated with Anti-CD47 Antibody (TAB-303LC) at a starting concentration of 2.5 µg/mL. The HRP-conjugated goat anti-human IgG was used as a secondary antibody.
Specifications
- Host Species
- Human
- Derivation
- Humanized
- Type
- Humanized antibody
- Specificity
- Human CD47 (cluster of differentiation 47)
- Species Reactivity
- Human
- Applications
- ELISA
- Related Disease
- Ischemia, Ischemia-reperfusion injury, Autoimmune diseases, Inflammatory diseases, Cancer
Product Property
- Purity
- >95% as determined by SDS-PAGE
- Buffer
- PBS
- Preservative
- No preservatives
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "CD47"
Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody
Humanized Antibody
Blocking Antibody
Neutralizing Antibody
Rabbit Monoclonal Antibody
Single-domain Antibody
Recombinant Antibody
Fab Fragment Antibody
scFv Fragment Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-278LC | Human Anti-CD47 Recombinant Antibody (TAB-278LC) | Block, FuncS | Human IgG, κ |
| TAB-279LC | Human Anti-CD47 Recombinant Antibody (TAB-279LC) | Block, FuncS | Human IgG, κ |
| TAB-278LC-S(P) | Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-278LC-S(P)) | ELISA | Human scFv |
| TAB-278LC-F(E) | Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-278LC-F(E)) | ELISA | Human Fab |
| TAB-279LC-F(E) | Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-279LC-F(E)) | ELISA | Human Fab |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-303LC. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: Neut, ELISA, IF, IP, FuncS, FC, IHC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
-1.png)
Application: ELISA, FC, Block, SPR
![Figure 1 Anti-Human CD19 Recombinant Antibody Fab Fragment [TAB-1611CL-F(E)] in SDS-PAGE](https://img.creativebiolabs.net/productimages/COA-TAB-1611CL-F(E)-1.png)
Application: Depletion, FuncS
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: Neut, ELISA, IF, IP, FuncS, FC
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
